001     140892
005     20240321220909.0
024 7 _ |a 10.1212/WNL.0000000000007606
|2 doi
024 7 _ |a pmid:31068484
|2 pmid
024 7 _ |a pmc:PMC6556095
|2 pmc
024 7 _ |a 0028-3878
|2 ISSN
024 7 _ |a 1526-632X
|2 ISSN
024 7 _ |a altmetric:60413775
|2 altmetric
037 _ _ |a DZNE-2020-07214
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Coarelli, Giulia
|b 0
245 _ _ |a Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.
260 _ _ |a [S.l.]
|c 2019
|b Ovid
264 _ 1 |3 online
|2 Crossref
|b Ovid Technologies (Wolters Kluwer Health)
|c 2019-05-08
264 _ 1 |3 print
|2 Crossref
|b Ovid Technologies (Wolters Kluwer Health)
|c 2019-06-04
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1592834855_1732
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Metalloendopeptidases
|0 EC 3.4.24.-
|2 NLM Chemicals
650 _ 7 |a SPG7 protein, human
|0 EC 3.4.24.-
|2 NLM Chemicals
650 _ 7 |a ATPases Associated with Diverse Cellular Activities
|0 EC 3.6.4.-
|2 NLM Chemicals
650 _ 2 |a White People: genetics
|2 MeSH
650 _ 2 |a ATPases Associated with Diverse Cellular Activities: genetics
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Cerebellar Ataxia: genetics
|2 MeSH
650 _ 2 |a Cerebellar Ataxia: physiopathology
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Electromyography
|2 MeSH
650 _ 2 |a European Continental Ancestry Group: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Loss of Function Mutation
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Metalloendopeptidases: genetics
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Paraplegia: genetics
|2 MeSH
650 _ 2 |a Paraplegia: physiopathology
|2 MeSH
650 _ 2 |a Phenotype
|2 MeSH
650 _ 2 |a Polymorphism, Single Nucleotide
|2 MeSH
650 _ 2 |a Spastic Paraplegia, Hereditary: genetics
|2 MeSH
650 _ 2 |a Spastic Paraplegia, Hereditary: physiopathology
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Schule, Rebecca
|0 P:(DE-2719)2812018
|b 1
|u dzne
700 1 _ |a van de Warrenburg, Bart P C
|b 2
700 1 _ |a De Jonghe, Peter
|b 3
700 1 _ |a Ewenczyk, Claire
|b 4
700 1 _ |a Martinuzzi, Andrea
|b 5
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 6
|u dzne
700 1 _ |a Hamer, Elisa G
|b 7
700 1 _ |a Baets, Jonathan
|b 8
700 1 _ |a Anheim, Mathieu
|b 9
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 10
|u dzne
700 1 _ |a Deconinck, Tine
|b 11
700 1 _ |a Masrori, Pegah
|b 12
700 1 _ |a Fontaine, Bertrand
|b 13
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 14
|u dzne
700 1 _ |a D'Angelo, Maria Grazia
|b 15
700 1 _ |a Monin, Marie-Lorraine
|b 16
700 1 _ |a De Bleecker, Jan
|b 17
700 1 _ |a Migeotte, Isabelle
|b 18
700 1 _ |a Charles, Perrine
|b 19
700 1 _ |a Bassi, Maria Teresa
|b 20
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 21
|u dzne
700 1 _ |a Mochel, Fanny
|b 22
700 1 _ |a Ollagnon-Roman, Elisabeth
|b 23
700 1 _ |a D'Hooghe, Marc
|b 24
700 1 _ |a Kamm, Christoph
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Kurzwelly, Delia
|0 P:(DE-2719)2811322
|b 26
|u dzne
700 1 _ |a Papin, Melanie
|b 27
700 1 _ |a Davoine, Claire-Sophie
|b 28
700 1 _ |a Banneau, Guillaume
|b 29
700 1 _ |a Tezenas du Montcel, Sophie
|b 30
700 1 _ |a Seilhean, Danielle
|b 31
700 1 _ |a Brice, Alexis
|b 32
700 1 _ |a Duyckaerts, Charles
|b 33
700 1 _ |a Stevanin, Giovanni
|b 34
700 1 _ |a Durr, Alexandra
|0 P:(DE-HGF)0
|b 35
|e Corresponding author
773 1 8 |a 10.1212/wnl.0000000000007606
|b : Ovid Technologies (Wolters Kluwer Health), 2019-05-08
|n 23
|p e2679-e2690
|3 journal-article
|2 Crossref
|t Neurology
|v 92
|y 2019
|x 0028-3878
773 _ _ |a 10.1212/WNL.0000000000007606
|g Vol. 92, no. 23, p. e2679 - e2690
|0 PERI:(DE-600)1491874-2
|n 23
|q 92:23|p e2679-e2690
|t Neurology
|v 92
|y 2019
|x 0028-3878
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556095
909 C O |o oai:pub.dzne.de:140892
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2812018
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810795
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2810314
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2810704
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2811322
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 1
914 1 _ |y 2019
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2022-11-12
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROLOGY : 2021
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NEUROLOGY : 2021
|d 2022-11-12
920 1 _ |0 I:(DE-2719)5000024
|k AG Maetzler
|l Functional Neurogeriatrics
|x 0
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser 1
|l Parkinson Genetics
|x 1
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls 1
|l Clinical Neurogenetics
|x 2
920 1 _ |0 I:(DE-2719)1011101
|k Patient studies, Bonn
|l Patient studies
|x 3
920 1 _ |0 I:(DE-2719)1111016
|k Clinical Dementia Research München
|l Clinical Dementia Research München
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000024
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21